# ANI PHARMACEUTICALS, INC (ANIP) FY2026 YTD Q2 P&L / Income Statement

- Company: ANI PHARMACEUTICALS, INC (ANIP)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-07, accession number 0001023024-26-000069
- Page: https://plicit.ai/financials/anip/fy2026-ytd-q2-income-statement
- Chart image: https://plicit.ai/charts/anip-fy2026-ytd-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2026-01-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net Revenues**: 503,506,000 US dollars
- **Cost of revenue (calculated)**: 193,740,000 US dollars
- **Gross profit (calculated)**: 309,766,000 US dollars
- **Operating expenses (calculated)**: 230,418,000 US dollars
- **Operating income**: 79,348,000 US dollars
- **Other income (expense), net (calculated)**: negative 2,030,000 US dollars
- **Income Before Income Tax Expense**: 77,318,000 US dollars
- **Income tax expense**: 23,115,000 US dollars
- **Net Income**: 54,203,000 US dollars
- **Generic pharmaceutical products**: 204,453,000 US dollars
- **Other generic revenues**: 5,423,000 US dollars
- **Brands**: 24,141,000 US dollars
- **Brand royalties and other revenues**: 39,271,000 US dollars
- **Cortrophin Gel**: 192,245,000 US dollars
- **ILUVIEN and YUTIQ**: 37,973,000 US dollars
- **Cost of sales (excluding depreciation and amortization)**: 193,740,000 US dollars
- **Research and development**: 25,347,000 US dollars
- **Selling, general, and administrative**: 165,316,000 US dollars
- **Depreciation and amortization**: 40,559,000 US dollars
- **Contingent consideration fair value adjustment**: negative 804,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/anip/fy2026-ytd-q2-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/anip-fy2026-ytd-q2-revenue-by-business-segment-sankey.png

Income statement for 2026-01-01 through 2026-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net Revenues**: 503,506,000 US dollars
- **Cost of revenue (calculated)**: 193,740,000 US dollars
- **Gross profit (calculated)**: 309,766,000 US dollars
- **Operating expenses (calculated)**: 230,418,000 US dollars
- **Operating income**: 79,348,000 US dollars
- **Other income (expense), net (calculated)**: negative 2,030,000 US dollars
- **Income Before Income Tax Expense**: 77,318,000 US dollars
- **Income tax expense**: 23,115,000 US dollars
- **Net Income**: 54,203,000 US dollars
- **Generics and Other**: 209,876,000 US dollars
- **Rare Disease and Brands**: 293,630,000 US dollars
- **Cost of sales (excluding depreciation and amortization)**: 193,740,000 US dollars
- **Research and development**: 25,347,000 US dollars
- **Selling, general, and administrative**: 165,316,000 US dollars
- **Depreciation and amortization**: 40,559,000 US dollars
- **Contingent consideration fair value adjustment**: negative 804,000 US dollars
- **Generics and Other costs (calculated)**: 133,064,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Rare Disease and Brands costs (calculated)**: 205,031,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Reconciling items (calculated)**: 86,063,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.